SCHEMBL7698689

SCHEMBL7698689

Cn1c(=O)c(-c2ccccc2)nc2cnc(Cl)cc21

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 15/20 0.61
GAA P10253 2/20 0.61
HPGD P15428 2/20 0.61
KDM4E B2RXH2 1/20 0.61
CYP1A2 P05177 18/20 0.53
CYP3A4 P08684 6/20 0.53
TSHR P16473 2/20 0.53
CLK4 Q9HAZ1 1/20 0.53
HSD17B10 Q99714 13/20 0.53
CASP7 P55210 11/20 0.53
CASP1 P29466 11/20 0.53
CYP2C9 P11712 7/20 0.53
HIF1A Q16665 6/20 0.53
CYP2C19 P33261 5/20 0.53
GLA P06280 5/20 0.53
TP53 P04637 2/20 0.53
MAPK1 P28482 1/20 0.53
USP2 O75604 9/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14006981 0.82 ALDH1A1 (0.66) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL28736705 0.81 ALDH1A1 (0.68) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL16332477 0.80 ATM (0.57) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL7694121 0.80 CYP1A2 (0.63) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL28736745 0.77 ALDH1A1 (0.68) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL7694822 0.77 CYP1A2 (0.68) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL17119622 0.77 SRC (0.53) BRD4
SCHEMBL14006985 0.76 ALDH1A1 (1.00) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL1963121 0.73 ALDH1A1 (0.70) ALDH1A1GAAHPGDKDM4ECYP1A2
SCHEMBL28736739 0.73 ALDH1A1 (0.65) ALDH1A1GAAHPGDKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076954-A1 COMPOUNDS USEFUL AS KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES SMITHKLINE BEECHAM CORPORATION (US) 2002-10-03 WO disclosed